A 26 week open label, flexible dose trial of Asenapine e

  • Kumra, Sanjiv (PI)

Project: Research project

Project Details

Description

A 26 week open label, flexible dose trial of Asenapine extension treatment to PO6107 in Pediatric Acute Manic or mixed episodes associated with BP1 disorder PO5898
StatusFinished
Effective start/end date8/1/125/30/14

Funding

  • SCHERING-PLOUGH CORPORATION

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.